Related Experiment Video

Updated: Jun 21, 2025

An Orthotopic Murine Model of Human Prostate Cancer Metastasis
06:48

An Orthotopic Murine Model of Human Prostate Cancer Metastasis

Published on: September 18, 2013

35.1K

GPC2 promotes prostate cancer progression via MDK-mediated activation of PI3K/AKT signaling pathway

Sijin Chen1, Jiaxing Liao1, Juhua Li1

  • 1Department of Urology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Changsha, 410005, Hunan Province, China.

Functional & Integrative Genomics
|July 16, 2024
PubMed

Insights

Glypican-2 (GPC2) acts as an oncogene in prostate cancer, promoting tumor growth and metastasis. Targeting GPC2 may offer a new therapeutic strategy for advanced prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Prostate cancer poses a significant global health challenge, with advanced stages remaining incurable.
  • Glypican-2 (GPC2) has emerged as a molecule of interest in oncology, but its role in prostate cancer is unexplored.
  • Understanding GPC2's regulatory mechanisms is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the role and regulatory mechanisms of Glypican-2 (GPC2) in prostate cancer.
  • To determine the correlation between GPC2 expression and prostate cancer progression and patient survival.
  • To elucidate the signaling pathways involved in GPC2-mediated tumor promotion.

Main Methods:

  • Quantitative analysis of GPC2 expression in prostate cancer tissues and cell lines.
  • Correlation studies between GPC2 levels and clinicopathological features (Gleason score, metastasis, survival).
  • In vitro experiments assessing the effects of GPC2 modulation on cell proliferation, migration, and invasion, including rescue assays involving MDK and PI3K/AKT signaling.

Main Results:

  • GPC2 expression is upregulated in prostate cancer tissues and cell lines.
  • Elevated GPC2 correlates with higher Gleason score, lymphatic metastasis, and poorer patient survival.
  • GPC2 knockdown inhibits, while overexpression promotes, prostate cancer cell proliferation, migration, and invasion.
  • GPC2 activates the PI3K/AKT signaling pathway via MDK, and MDK can partially rescue GPC2 knockdown effects.

Conclusions:

  • Glypican-2 (GPC2) functions as an oncogene in prostate cancer.
  • GPC2 promotes prostate cancer progression through MDK-mediated activation of the PI3K/AKT pathway.
  • GPC2 represents a potential prognostic biomarker and therapeutic target for prostate cancer.
Keywords:
GPC2MDKPI3K/AKT signalingProstate cancer

More Related Videos

RhoC GTPase Activation Assay09:58

RhoC GTPase Activation Assay

Published on: August 22, 2010

12.4K
Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration10:43

Methods to Study Mrp4-containing Macromolecular Complexes in the Regulation of Fibroblast Migration

Published on: May 19, 2016

6.7K

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.4K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
12.0K